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Abstract
OBJECTIVE:We wished to study the impact of Chai-
hushugan San (CSS) on the behavior of perimeno-
pausal rats with liver-Qi stagnation (LQS) and to in-
vestigate the effect of CSS on signal transduction
of the Raf/mitogen-activated protein kinase (MEK)/
extracellular signal-regulated kinase (ERK) cascade
in the hippocampi of rats induced by immobiliza-
tion.
METHODS: Twenty 52-week-old female rats were
divided into two groups by the random number ta-
ble method: model control group (MCG) and CSS
group (CSSG), with 10 rats in each group.
Ten-week-old female rats were used as the normal
control group (NCG). CSS effects were assessed us-
ing rats exposed to immobilization stress by mea-
suring body weight and sucrose consumption, se-
rum hormone levels, and observing performance
in the open field test (OFT). Molecular mechanisms
were examined by measuring the effect of CSS on
expression of Raf1, MEK1/2 and ERK1/2 mRNA in
hippocampi using quantitative real-time poly-
merase chain reaction and by measuring levels of
these proteins and related phospho-proteins using
Western blotting.
RESULTS: Perimenopausal rats with LQS had de-
creased locomotor activity; reduced sucrose con-
sumption; and increased serum levels of corticotro-
pin releasing hormone (CRH) and corticosterone
(CORT). Activation of hippocampal Raf/MEK/ERK
cascade was suppressed significantly in the MCG,
and activation was increased after 21 days of CSS
treatment.
CONCLUSION: CSS has significant effects upon re-
lief of the symptoms of LQS in immobilization-in-
duced rats. The mechanism underlying this action
might (at least in part) be mediated by reversal of
disruption of the Raf/MEK/ERK pathway.
© 2015 JTCM. All rights reserved.
Key words: Perimenopausal syndrome; Stagnation
of liver Qi; MAP kinase signaling system; Chaihush-
ugan San
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INTRODUCTION
Perimenopausal syndrome (PMS) is caused by decreas-
ing estrogen levels during menopause and can severely
impair quality of life.1,2 Hormone replacement therapy
is one of the most effective treatments for the symp-
toms of PMS. However, in recent years, epidemiologic
studies have identified potentially serious adverse reac-
tions to hormone replacement therapy, including an in-
crease in the risk of stroke, deep-venous thrombosis, de-
mentia and breast cancer.3
Numerous plants and their constituents have been
shown to possess beneficial properties against various
diseases, including PMS.4,5 Traditional Chinese medi-
cine (TCM) is based on the treatment of medical con-
ditions by identification of symptom patterns. One
TCM symptom pattern, liver-Qi stagnation (LQS), is a
key factor in the pathogenesis of PMS.6,7 Decoctions
prepared with medicines prescribed on the basis of dis-
persing LQS can relieve PMS symptoms.8
Chaihushugan San (CSS) is documented in a classic of
medical literature in China: Jingyue Quanshu.9 CSS is
used to treat various symptoms inherent in LQS,10-12 es-
pecially depression. Increasing numbers of studies have
reported the effect of CSS (or its constituents or ex-
tracts) on depression, and confirmed its antidepressant
effect.10,13,14 Recent studies have demonstrated that CSS
can alleviate depressive-like conditions as well as re-
duce levels of adrenocorticotropic hormone (ACTH)
and cortisol in a rat model of LQS.15-17 CSS has also
been shown to significantly increase the numbers of ex-
tracellular signal-regulated kinase (ERK)1/2- and
p-ERK-positive cells in the hippocampi of stressed rats.
However, the exact mechanism of action underlying
the positive effect of CSS on LQS remains unclear. We
wished to evaluate the effect of CSS in dispersal of
LQS for the relief of its symptoms in rats.
MATERIALS ANDMETHODS
Ethical approval of the study protocol
All experimental procedures followed a protocol ap-
proved by the Animal Ethics Committee of the Institu-
tion of Research Animal Care, Fujian University of Tra-
ditional Chinese Medicine (Fujian, China).
Drugs and reagents
Enzyme-linked immunosorbent assay (ELISA) kits for
ACTH (catalog number F15031), corticotropin-releas-
ing hormone (CRH; F15272) and corticosterone
(CORT; F1812) were purchased from Shanghai Wes-
tang Biotech (Shanghai, China). Radioimmunoprecipi-
tation assay (RIPA) buffer (catalog number
AR0103-100) was purchased from Boster Biological
Technology (Wuhan, China). Raf1 (Y198; ab32025)
antibody, ERK1+ERK2 antibody (ab17942) and β-ac-
tin antibody were purchased from Abcam (Cambridge,
MA, USA). ERK1/2 (Phospho-Thr202/Tyr204) anti-
body (catalog number 4370) was supplied by Cell Sig-
naling Technology (Beverly, MA, USA). Mitogen-acti-
vated protein kinase kinase (MEK)1/MEK2 (Ab-217/
221) antibody (catalog number 21203), Raf1 (Phos-
pho-Ser259) antibody (catalog number 11006) and
MEK1/MEK2 (Phospho-ser217/Ser221) antibody
(11205) were purchased from Signalway Antibodies
(Pearland, TX, USA). SuperSignal West Femto maxi-
mum sensitivity substrate (catalog number 34095) was
supplied by Thermo Scientific (Waltham, MA, USA).
ECL-plus (catalog number P0018-2) was purchased
from Beyotime (Beijing, China).
Instruments and equipment
A Microplate Reader was sourced from Biotek
(Elx800; Winooski, VT, USA). Polymerase chain reac-
tion (PCR) instruments were supplied by Applied Bio-
systems (ABI Veriti 96 and ABI 7500 Fast; Foster City,
CA, USA). Electrophoresis equipment was obtained
from Bio-Rad (Gel Doc XR; Hercules, CA, USA). A
Desktop High-speed Refrigerated Centrifuge was sup-
plied by Eppendorf AG (5417R; Hamburg, Germany).
A NanoDrop ND-2000 Spectrophotometer was pur-
chased from Thermo Scientific. A FluorChem M Digi-
tal Darkroom was provided by ProteinSimple (Santa
Clara, CA, USA).
Preparation of CSS
A standard solution of CSS was prepared according to
the formula provided in the Jingyue Quanshu. CSS for-
mulation comprised the following Chinese herbs (in
g): Chaihu (Radix Bupleuri Chinensis) 6 g; Chenpi
(Pericarpium Citri Reticulatae) 6 g; Chishao (Radix Pae-
oniae Rubra) 4.5 g; Gancao (Radix Glycyrrhizae) 1.5 g;
Zhiqiao (Fructus Aurantii Submaturus) 4.5 g; Chuanx-
iong (Rhizoma Chuanxiong) 4.5 g; Xiangfu (Rhizoma
Cyperi) 4.5 g. Constituents of CSS are complex and in-
clude monoterpene glycosides, galloyl glucoses, pheno-
lic compounds, lactones, flavonoids, and triterpene sa-
ponins.18-22
Raw components of the CSS formulation were mixed
and soaked in distilled water for 30 min. Ten-volumes
of cold deionized water were added to the herbs and
boiled for 30 min. Then, the residue was extracted
twice in the same volume of water. Finally, the aqueous
extract was collected and mixed with the former ex-
tract, passed through filter paper and condensed to
one-tenth of the volume by rotary evaporation at 80 ±
5 rpm and (60 ± 1) ℃. Preparation of the aqueous ex-
tract described here is essentially the same as that of
"traditional" CSS.
Animals and administration
Twenty female specific pathogen-free Sprague-Dawley
rats (340-380 g; Beijing Vital River Laboratory Animal
Technology, Beijing, China; license number, SCXK
(Jing) 2012-0001) were housed for 3 months in rooms
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set at 55% humidity and 23 ℃ with a 12-h light-dark
cycle before modeling. Ten-week-old female rats
(260-300 g; n = 10) were used as a normal control group
(NCG). All mice were killed under ketamine anesthe-
sia and all efforts were made to minimize suffering.
Rat models of the TCM symptom pattern of PMS
LQS were created by immobilization stress, as de-
scribed previously with some modifications.23 Briefly,
modeled rats were confined to a stack for 3 h every
day and kept in separate cages throughout the experi-
ment. CSS was administered to the CSS group
(CSSG) simultaneously while the model was being es-
tablished. CSS was administrated by gavage [1000 mg/
kg body weight (BW)], whereas the NCG and mod-
el control group (MCG) were given water by gavage
(10 mL/kg BW). CSS treatment continued for 21
days. Stages of the estrous cycle were monitored by
microscopic examination of vaginal smears. Rats be-
longing to the MCG and CSSG were in the diestrus
stage of the cycle.
Behavioral assessments
Sucrose consumption test (SCT) and the open field
test (OFT) were used for evaluation of LQS. SCT
was undertaken on day-1 and day-21 of the experi-
ment. Rats were deprived of food and water for 24 h
before the SCT and then provided with sucrose solu-
tion (1% sucrose) and drinking water for the next 1
h. Sucrose intake was measured by comparing the
weight of bottles before and after the SCT. OFT
was carried out to assess emotional behavior and lo-
comotor activity according to methods described pre-
viously.24
Measurement of serum levels of CRH, ACTH and
CORT
Serum levels of CRH, ACTH and CORT were mea-
sured using ELISA kits (Shanghai Westang Biotech) ac-
cording to manufacturer instructions. Absorbance was
measured at 450 nm using a Microplate Reader
(Elx800; Biotek).
Tissue preparation
Rats were anaesthetized with intraperitoneal injections
of ketamine. Blood was collected from the abdominal
aorta for sera preparation. The hippocampus was re-
moved, and immersed in liquid nitrogen immediately.
Measurement of hippocampal mRNA expression
using quantitative real-time reverse
transcription-polymerase chain reaction (qRT-PCR)
The level and purity of RNA were measured using the
NanoDrop ND-2000 Spectrophotometer (Thermo Sci-
entific). PCR primers, as listed in Table 1, were de-
signed and synthesized by Takara (Otsu, Japan). Rela-
tive expression of mRNA of target genes was calculated
using the 2–ΔΔCt method. Relative amplification efficien-
cies of primers were tested and observed to be similar.
Expression in the NCG was designated as 100%, and
expression levels in the other groups recorded relative
to that in the NCG.
Detection of related proteins by western blotting
Total protein in the hippocampus was extracted with
RIPA buffer. A protein assay kit was used for concen-
tration measurement. After blocking with 5% skim
milk for 2 h, Raf1 (1∶500 dilution), p-Raf1 (1∶400),
MEK1/2 (1∶1000), p-MEK1/2 (1∶400), ERK1/2 (1∶
1250) and p-ERK1/2 (1∶1000) antibodies were added,
and plates shaken overnight at 4℃. Results were visual-
ized using the Fluor Chem M Digital Darkroom (Pro-
teinSimple, San Jose, CA, USA). Stained bands were
analyzed with software to calculate the gray value.
Gray values of apoptosis inhibitor of macrophage pro-
tein/β-actin were taken as the relative value of AIM
protein expression in the hippocampus.
Statistical analyses
Data were analyzed using InStat v6.0 (GraphPad,
La Jolla, CA, USA). Data are the mean ± standard devi-
ation ( xˉ ± s). Analysis of variance was used to assess
differences between groups. All statistical tests were
two-sided and P < 0.05 was considered significant.
Gene
Raf1
ERK1
ERK2
MEK1
MEK2
GAPDH
Primer sequence
F: 5 GGTCAATGTGCGGAATGGG 3
R: 5 CAATCAGAGAGGCGGCGTC 3
F: 5 CCAGAGTGGCTATCAAGAAG 3
R: 5 TCCATGAGGTCCTGAACAA 3
F: 5 TGCCGTGGAACAGGTTGT 3
R: 5 TGGGCTCATCACTTGGGT 3
F: 5 AGCTAATTGACTCCATGGCCAAC3
R: 5 TGGCATCCAAACAGCAGCTC3
F: 5 GCAGTCTGTGTCCTTGTCCTGT3
R: 5 CTCTCTTTCTCCACTTTGTTTGCT3
F: 5 GGAAAGCTGTGGCGTGAT 3
R: 5 AAGGTGGAAGAATGGGAGTT 3
Product (bp)
150
181
153
193
120
308
Accession number
NM_012639.2
NM_017347.2
NM_053842.1
NM_031643.4
NM_133283.1
NM_017008.4
Table 1 Primer sequences and length of PCR products
Notes: F: forward; R: reverse; ERK: extracellular signal-regulated kinase; MEK: mitogen-activated protein kinase kinase; GAPDH: glyceral-
dehyde 3-phosphate dehydrogenase.
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RESULTS
Validation of rats used in the study
BW was recorded on day-1 and day-21. Figure 1 shows
changes in BW of all rats during the experimental peri-
od. The initial weight difference between the MCG
and CSSG was not significant (P > 0.05). BW of the
NCG increased from day-1 to day-21, that of the
MCG decreased significantly (P < 0.01), and that of
the CSSG decreased only slightly. These observations
suggested that CSS ameliorated LQS in rats.
Changes in the duration of the estrous cycle are shown
in Figure 2. We identified a normal estrous cycle in
NCG rats and a disturbed cycle in MCG and CSSG
rats. These results not only suggested that the duration
of the estrous cycle was not affected by CSS treatment
(P > 0.05) but also confirmed that aging rats could be
used as a model of PMS women.
Effects on OFT activity scores
OFT was conducted on day-1 and day-21. On day-1,
there was no significant difference (P > 0.05) in the
number of lines crossed or rearing frequency in the
OFT between the MCG and CSSG (Figure 3). On
day-21, the MCG showed poorer OFT performance,
including a lower number of lines crossed and a low-
er rearing frequency, compared with the CSSG. The
number of lines crossed and rearing frequency were
also decreased significantly in the MCG compared
with the NCG on day-21 ( P < 0.01, respectively ).
These findings verified the LQS pattern in the
MCG, and suggested that CSS can ameliorate LQS
in rats.
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Figure 1 Changes in body weight in the three groups over
the experimental period
NCG: normal control group, was treated with 10 mL/kg wa-
ter for 21 days; MCG: model control group, was confined on
a stack for 3 h every day and treated with 10 mL/kg water
for 21 days; CSSG: ChaihuShugan San group, was confined
on a stack and treated with 1000 mg/kg Chaihu Shugan San
for 21 days. The weight difference between MCG and CSSG
at the beginning was not significant (P > 0.05). MCG and
CSSG had a significantly decreased end weight on day-21
compared with that on day-1 (a,bP < 0.01, respectively). Rats
in the CSSG showed a significant increase in the body
weight compared with MCG rats (cP < 0.01) on day-21. Data
are the mean ± standard deviation (n = 10).
Figure 2 Duration of the estrous cycle in the three groups
NCG: normal control group, was treated with 10 mL/kg water
for 21 days; MCG: model control group, was confined on a
stack for 3 h every day and treatedwith 10mL/kgwater for 21
days; CSSG: ChaihuShugan San group, was confined on a
stack and treated with 1000 mg/kg Chaihushugan San for 21
days. Duration of the estrous cycle was significantly pro-
longed inMCGandCSSG rats than inNCG rats (aP<0.01), there
was no significant difference between theMCG andCSSG (P>
0.05).Dataare themean±standarddeviation (n = 10).
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Figure 3 Results of the open field test for the three groups
A: number of line crossings during a 5-min session. B: num-
ber of rearings during a 5-min session. NCG: normal control
group, was treated with 10 mL/kg water for 21 days; MCG:
model control group, was confined on a stack for 3 h every
day and treated with 10 mL/kg water for 21 days; CSSG: Chai-
huShugan San group, was confined on a stack and treated
with 1000 mg/kg Chaihushugan San for 21 days. The open
field test was carried out on day-1 and day-21. There were
no significant differences in the number of crossings or rear-
ings in the open-field test (P > 0.05) among the three groups
on day-1. The number of crossings and rearings in the MCG
decreased significantly when compared with the NCG (aP <
0.01) on day-21. CSSG showed a significant increase in cross-
ings and rearings compared with the MCG on day-21 (bP <
0.01). Data are the mean ± standard deviation (n= 10).
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Effects on sucrose consumption
SCT was done on day-1 and day-21. There was no sig-
nificant difference in sucrose consumption between the
MCG and CSSG group on day-1 (P > 0.05), and con-
sumption was higher in the NCG than in the MCG or
CSSG. On day-21, sucrose consumption in the MCG
was significantly lower than that in the MCG (P <
0.01) on day-1, and sucrose consumption in the CSSG
was significantly higher than that in the MCG (P <
0.01, Figure 4).
Serum levels of CRH, ACTH and CORT
Serum levels of CRH, ACTH and CORT were signifi-
cantly higher in the MCG compared with the NCG (
P < 0.01, respectively ) (Table 2). Serum levels of
CRH and CORT decreased after 21-day CSS treat-
ment. The ACTH level also decreased but did not
change significantly (P > 0.05).
mRNA expression of raf1, MEK1/2 and ERK1/2 in
the hippocampus
Analyses of raf1, MEK1/2 and ERK1/2 mRNA in hip-
pocampal samples from the NCG, MCG and CSSG
were undertaken to investigate the potential involve-
ment of the raf/MEK/ERK signaling pathway in the
hippocampus of PMS rats with LQS. RT-PCR analy-
ses showed that expression of MEK2 and ERK2 was
decreased significantly in the MCG compared with the
NCG (P < 0.05), but increased significantly after
21-day CSS treatment (CSSG vs MCG) (P < 0.05).
There was no significant difference in the expression of
raf1, MEK1 or ERK1 mRNA in hippocampal samples
from the MCG and CSSG (P > 0.05, Figure 5).
Protein levels of raf1, p-raf1, MEK1/2, p-MEK1/2,
ERK1/2 and p-ERK1/2 in the hippocampus
Levels of raf1, p-raf1, MEK1/2, p-MEK1/2, ERK1/2,
p-ERK1/2 and β-actin in the hippocampus were mea-
sured. There was no significant difference in hippocam-
pal Raf1, MEK1/2 and ERK1/2 among the groups
(P > 0.05) (Figure 6B). However, there were signifi-
cant differences in levels of p-Raf1, p-MEK1/2 and
p-ERK1/2 among the groups (P < 0.05). Levels of
these three proteins in the MCG were decreased signifi-
cantly (P < 0.01) compared with those in the NCG,
and increased significantly after 21 days of CSS treat-
ment (CSSG vsMCG) (P < 0.01, Figure 6C).
DISCUSSION
Recently, rat models have been developed to mimic the
symptoms of LQS. Sprague-Dawley rats are more re-
sponsive to antidepressants than the Wistar strain and
have, therefore, been proposed as an animal model of
depressive behaviour.25 Development of rat models by
immobilization stress has been used widely for the
study of behaviors associated with depression, mecha-
nisms of action of antidepressants, and other biochemi-
cal changes. OFT has been used to assess emotionality
and locomotor performance, and the SCT is consid-
ered valid for the two core symptoms of major depres-
sion: anhedonia and depressed mood.26 These tests
have been used widely to assess the behavior of rats
with LQS.15,27
We evaluated the estrous cycle in ageing rats by micro-
scopic examination of vaginal smears. We kept ageing
rats isolated and in a confined space to induce a state
similar to that typical of PMS women with LQS. Rats
in the MCG showed behavioral and physical changes,
including decreased weight gain, decreased locomotor
activity in the OFT, increased serum levels of CRH
Groups
NCG
MCG
CSSG
n
10
10
10
ACTH (ng/L)
237.46±13.47
304.32±14.38a
278.36±14.97
CRH (ng/mL)
0.84±0.22
2.38±0.30b
1.43±0.19c
CORT (μg/L)
45.35±5.18
69.83±7.27d
50.37±5.52
Notes: NCG: normal control group, was treated with 10 mL/kg water for 21 days; MCG: model control group, was confined on a stack
for 3 h every day and treated with 10 mL/kg water for 21 days; CSSG: ChaihuShugan San group, was confined on a stack and treated
with 1000 mg/kg Chaihushugan San for 21 days. Data are presented as means ± SD (n = 10), aP < 0.01 for the MCG compared with the
NCG; bP < 0.01 for the MCG compared with the NCG; cP < 0.01 for the CSSG compared with the MCG; dP < 0.01 for the MCG com-
pared with the NCG.
Table 2 CRH, ACTH, CORT content in serum of 3 groups ( xˉ ± s)
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Figure 4 Sucrose consumption test in the three groups
NCG: normal control group, was treated with 10 mL/kg wa-
ter for 21 days; MCG: model control group, was confined on
a stack for 3 h every day and treated with 10 mL/kg water
for 21 days; CSSG: ChaihuShugan San group, was confined
on a stack and treated with 1000 mg/kg Chaihushugan San
for 21 days. Sucrose consumption in the MCG was signifi-
cantly lower than that in the NCG (aP < 0.01). Sucrose con-
sumption of the CSSG was higher than that in the MCG (bP <
0.05). Data are the mean ± standard deviation (n = 10).
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Figure 5 Expression of raf1, MEK1/2 and ERK1/2 mRNA in hippocampal samples from the three groups
NCG: normal control group, was treatedwith 10mL/kgwater for 21 days; MCG:model control group, was confined on a stack for 3 h
every day and treated with 10 mL/kg water for 21 days; CSSG: ChaihuShugan San group, was confined on a stack and treated with
1000 mg/kg Chaihushugan San for 21 days. Expression of Raf1, Mek1, and ERK1 mRNA showed no significant difference among all
groups. Expression of Mek2 and ERK2 mRNA decreased in the MCG, and then increased, after 21-day CSS treatment. aP < 0.05, for
the CSSG comparedwith theMCG; bP< 0.05, for the CSSG comparedwith theMCG. Data are themean ± standard deviation (n= 10).
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Figure 6 Expression of raf1, MEK1/2 and ERK1/2 protein in hippocampal samples from the three groups
A: western blotting analyses of protein levels in hippocampal tissue in the NCG, MCG and CSSG; 1: NCG; 2: MCG; 3:CSSG. B: Protein
levels in the hippocampi of different rat groups; C: Phosphorylated protein levels in the hippocampi of 3 groups. NCG: normal
control group, was treated with 10 mL/kg water for 21 days; MCG: model control group, was confined on a stack for 3 h every day
and treated with 10 mL/kg water for 21 days; CSSG: ChaihuShugan San group, was confined on a stack and treated with 1000 mg/
kg Chaihushugan San for 21 days. There were no significant differences in hippocampal levels of Raf1, Mek1/2, ERK1/2 between
the groups (P > 0.05). However, levels of p-raf1, p-MEK1/ and p-ERK1/2 protein in the MCG decreased compared with the NCG,
then increased after 21-day CSS treatment. Data are the mean ± standard deviation (n = 10).
and CORT, and reduced consumption of sucrose, all
of which mimicked LQS symptoms.
Metabolic disorder of monoamine neurotransmitters
in the central nervous system is the main biochemical
feature of depression. CSS can reduce levels of ACTH
and cortisol in a rat model of LQS.15-17 Studies have
suggested that levels of the monoamine neurotransmit-
ters 5-hydroxytryptamine (5-HT) and norepinephrine
(NE) in rat models of PMS LQS are significantly de-
creased compared with controls but that, after CSS
treatment, levels of 5-HT and NE increase significant-
ly.16,17,27
Results of the present study strongly suggest that use of
CSS to treat PMS is rational and efficacious, but the
underlying mechanism of action of CSS is not known.
MEK signaling has been implicated in brain develop-
ment, long-term memory, and response to antidepres-
sants. Raf/MEK/ERK is a three-layered kinase cascade
comprising Ser/Thr kinase Raf (i.e., A-Raf, B-Raf, or
C-Raf/Raf-1), the highly homologous dual-specificity
kinases MEK1 and MEK2, and ubiquitously expressed
Ser/Thr kinase ERK1 and its homolog ERK2.28-31 The
Raf/MEK/ERK pathway has a essential role in promot-
ing cell proliferation, and its deregulated activation is a
central signature of many types of cancer.32,33 Also, sus-
tained activity of Raf/MEK/ERK can result in growth
arrest in many cell types.34
The present study demonstrated that the mRNA ex-
pression of MEK2 and ERK2 was suppressed in the
MCG, and that CSS treatment might induce stimula-
tion of expression of MEK2 and ERK2. In additional
western-blotting experiments, levels of p-raf1, p-mek1/
2, p-erk1,2 in the MCG were decreased significantly
compared with those in the NCG, but increased signif-
icantly after 21 days of CSS treatment (CSSG vs
MCG). These findings were almost in accordance with
the results presented by Du et al,35 who found that
CSS significantly improved the numbers of ERK1/2-
and p-ERK-positive cells in cornu ammonis3 and den-
tate gyrus sections of the hippocampus.
Studies focusing on the effect of CSS on the Raf/MEK/
ERK pathway in LQS are lacking. Wang et al 36 ob-
served a gene–gene interaction in the Ras/Raf/MAPK
signaling pathway in depressed female patients, found
that antidepressant efficacy may through mediating the
pharmacological action of an antidepressant. Other
studies have also suggested a relationship between CSS
and the ERK signaling pathway in depression. Wang et
al 37 reported that unpredicted chronic mild stress
down-regulated ERK1/2 expression in rat hippocampi,
and that CSS increased ERK1/2 expression. Our find-
ings suggest that the effect of CSS on LQS was related
to the Raf/MEK/ERK pathway, and that CSS could re-
verse the stress-induced disruption of activation of the
Raf/MEK/ERK pathway in the hippocampus.
CSS has a curative effect on model rats with symptoms
of LQS induced by immobilization stress. The mecha-
nism of the action might (at least in part) be mediated
through the Raf/MEK/ERK pathway. Our findings
provide valuable information for further elucidation of
the molecular mechanism of action of CSS for PMS
treatment.
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